Xalles Holdings to Launch New ArtemisX Defense Company to Capitalize on the U.S. Uncrewed Systems Market
Xalles Holdings Inc. ("Xalles") (OTC: XALL), a well-established holding company with a focus on innovative technology and financial services, today announced that the formation of ArtemisX Defense Inc. (“ArtemisX”), a new subsidiary focused on the uncrewed systems sector, is in progress. ArtemisX is being incorporated as a Florida C Corporation and represents the addition of a corporate entity designed specifically for the expansion of Xalles Holdings’ capabilities in the U.S. defense industry.
ArtemisX is being established with the strategic objective of leveraging some of the intellectual property, designs, and expertise of Artemis Defense Technologies UK Ltd. (“Artemis UK”), a wholly owned subsidiary of Xalles Holdings under the Xalles Security business group. The creation of ArtemisX is a calculated move to position the company for securing lucrative contracts for projects within the uncrewed systems market in the U.S., leveraging the advanced technological foundation of Artemis UK.
About Xalles Holdings Inc. (OTC: XALL)
Xalles Holdings Inc. is a leading holding company, specializing in innovative technology and financial service solutions. Focused on growth and diversification, Xalles Holdings is committed to developing cutting-edge technology-based solutions across various sectors, with an emphasis on supporting disruptive companies. Utilizing its proprietary Xalles RISE Business Model (Roll In, Selected Exit), the company actively seeks acquisition targets with solid management teams, robust business models, expansive total attainable markets (TAM), and enticing exit opportunities. Emphasizing the integration of blockchain and cutting-edge technologies, Xalles provides industry-leading solutions, poised to capture recurring revenue streams over time. Discover more at Xalles.com.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.
Investor Relations Contact:
IR: 202.779.1460